Literatur
- 1 www.unaids.org . AIDS epidemic update. December 2002
- 2 www.eurohiv.org . HIV/AIDS Surveillance in Europe 6/2002.
- 3
Rouzioux C, Costagliola D, Burgard M et al.
Estimated timing of mother-to-child human immunodeficiency virus type (HIV-1) transmission
by use of a Markov Model.
Am J Epidemiol.
1995;
142
1330-7
- 4
Blanche S, Newell M L, Mayaux M J et al.
Morbidity and mortality in European children vertically infected by HIV-1.
J Acquir Immune Defic Syndr Hum Retrovirol.
1997;
14
442-50
- 5
Centers for Disease Control.
Revised classification system for human immunodeficiency virus infection in children
less than 13 years of age.
MMWR.
1994;
43
1-19
- 6 www.hivatis.org . Guidelines for the use of antiretroviral agents in pediatric HIV
infection. December 14, 2001
- 7
Niehues T, Wintergerst U, Funk M, Notheis G et al.
Empfehlungen zur antiretroviralen Therapie bei HIV-infizierten Kindern.
Monatsschr Kinderheilk.
2001;
149
1372-82
- 8 Compagnucci A, Saidi Y, Chaix et al. Difficulties in achieving suppression of viral
replication in vertically HIV-1 infected infants early treated with d4T+ddI+NFV: The
PENTA 7 Study. 9th Conference on Retroviruses and Opportunistic Infections. February 24 - 28, 2002 Seattle
Poster Number 809-W
- 9 Tudor-Williams G, Head S, Weigel R et al. Baby Cocktail! A protease-sparing 4 drug
combination for symptomatic infants. XIV International AIDS Conference. July 7 - 12,
2002 Barcelona Abstract MoOrB1129
- 10
Connor E M, Sperling R S, Gelber R et al.
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with
zidovudine treatment.
N Engl J Med.
1994;
331
1173-80
- 11 www.rki.de . Deutsch-Österreichische Empfehlungen zur HIV-Therapie in der Schwangerschaft. Stand
Mai 2001
- 12
Grosch-Wörner I, Schäfer A, Obladen M et al.
An effective and safe protocol involving zidovudine and caesarean section to reduce
vertical transmission of HIV-infection.
AIDS.
2000;
14
2903-11
- 13
The International Perinatal HIV Group.
The mode of delivery and the risk of vertical transmission of human immunodeficiency
virus type 1 A meta-analysis of 15 prospective cohort studies.
N Engl J Med.
1999;
340
977-87
- 14
Carr A, Samaras K, Burton S et al.
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in
patients receiving HIV protease inhibitors.
AIDS.
1998;
12
F51-58
- 15
Babl F E, Regan A M, Pelton S M.
Abnormal body-fat distribution in HIV-infected children on antiretrovirals.
Lancet.
1999;
353
1243-4
- 16
Egger M, May M, Chene G et al.
Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy:
a collaborative analysis of prospective studies.
Lancet.
2002;
360
119-29
- 17
The European Collaborative Study.
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first
10 years of life.
Pediatrics.
2001;
108
116-22
Prof. Dr. med. Ilse Grosch-Wörner
Leiterin der Tagesklinik - Kinder Stat. 63
Charité Campus Virchow-Klinikum
Mittelallee 8
13353 Berlin
Phone: 030/4505-66501
Email: ilse.grosch-woerner@charite.de
